What does bioAffinity Technologies, Inc. do?
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and…
What is bioAffinity Technologies, Inc.'s P/E and P/B ratio?
bioAffinity Technologies, Inc. has a P/E ratio of -0.0 and a P/B ratio of 1.08.
What is bioAffinity Technologies, Inc.'s debt-to-equity ratio?
bioAffinity Technologies, Inc. has a debt-to-equity ratio of 0.38.
How much does bioAffinity Technologies, Inc. owe compared with what it owns?
bioAffinity Technologies, Inc. owes $0.51 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is bioAffinity Technologies, Inc.'s Positivity rank?
bioAffinity Technologies, Inc. is ranked #2,823 of 6,774 companies globally and #1,025 of 4,000 in United States on PositoAI, with a Positivity Score of 21,113.
Does bioAffinity Technologies, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. bioAffinity Technologies, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 31 Jul 2026). It has no yellow flags.
Where can I read the latest news about bioAffinity Technologies, Inc.?
Recent headlines about bioAffinity Technologies, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does bioAffinity Technologies, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of bioAffinity Technologies, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.